Registry of Patients With Chronic Thromboembolic Pulmonary Hypertension in Novosibirsk Region

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-01

Study Completion Date

2018-03-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There will be assessment of patients after acute pulmonary embolism for the development of CTEPH

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There will be assessment of patients after acute pulmonary embolism for the development of CTEPH.

There will be analysis of case histories of 40 patients with acute pulmonary embolism. All this patients will be clinically assessed by local cardiologist. Also echocardiography, lung VQ scans (perfusion and ventilation) will be performed.

Patients with chronic thromboembolic pulmonary hypertension will be assessed by local team experienced in CTEPH treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Thromboembolic Pulmonary Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

acute PE survivors

Patients from this group will be assessed by cardiologist, echocardiography and VQ scanning

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients who had episodes of acute pulmonary embolism
* 3-4 months of anticoagulation treatment after acute pulmonary embolism
* informed consent

Exclusion Criteria

* pregnancy

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Novosibirsk research institute of circulation pathology

Novosibirsk, Novosibirsk Oblast, Russia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Russia

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alexander Edemskiy, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCTEPHR

Identifier Type: -

Identifier Source: org_study_id